ADC Therapeutics (ADCT) Short Interest Ratio & Short Volume → The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad) Free ADCT Stock Alerts $4.68 -0.08 (-1.68%) (As of 03:46 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media ADC Therapeutics Short Interest DataCurrent Short Volume993,100 sharesPrevious Short Volume939,800 sharesChange Vs. Previous Month+5.67%Dollar Volume Sold Short$4.46 millionShort Interest Ratio / Days to Cover1.3Last Record DateMarch 31, 2024Outstanding Shares82,810,000 sharesFloat Size54,790,000 sharesShort Percent of Float1.81%Today's Trading Volume274,261 sharesAverage Trading Volume765,818 sharesToday's Volume Vs. Average36% Short Selling ADC Therapeutics ? Sign up to receive the latest short interest report for ADC Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatADCT Short Interest Over TimeADCT Days to Cover Over TimeADCT Percentage of Float Shorted Over Time Ad Gold Safe ExchangeThe “Perfect Storm” for GoldGold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! ADC Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2024993,100 shares $4.46 million +5.7%1.8%1.3 $4.49 3/15/2024939,800 shares $3.55 million +8.2%1.7%1.2 $3.78 2/29/2024868,800 shares $4.20 million -39.2%1.6%0.9 $4.83 2/15/20241,430,000 shares $7.11 million -51.2%2.7%1.5 $4.97 1/31/20242,930,000 shares $9.17 million -12.8%5.4%3.5 $3.13 1/15/20243,360,000 shares $7.16 million -9.7%6.2%5 $2.13 Get the Latest News and Ratings for ADCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ADC Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/31/20233,720,000 shares $6.18 million -8.2%6.8%6.1 $1.66 12/15/20234,050,000 shares $6.70 million -1.0%7.3%7.8 $1.66 11/30/20234,090,000 shares $3.49 million +13.0%7.7%12.3 $0.85 11/15/20233,620,000 shares $2.10 million -8.8%6.8%12.2 $0.58 10/31/20233,970,000 shares $2.78 million -23.7%7.5%14.6 $0.70 10/15/20235,200,000 shares $4.16 million -1.7%9.8%17.1 $0.80 9/30/20235,290,000 shares $4.75 million +3.1%9.9%11.7 $0.90 9/15/20235,130,000 shares $4.26 million +0.4%9.6%10.8 $0.83 8/31/20235,110,000 shares $6.18 million -4.0%8.1%11.1 $1.21 8/15/20235,320,000 shares $8.49 million -13.6%8.5%11.5 $1.60 7/31/20236,160,000 shares $9.15 million +4.1%9.8%11.9 $1.49 7/15/20235,920,000 shares $8.94 million -3.7%9.4%11.8 $1.51 6/30/20236,150,000 shares $13.25 million +1.2%9.8%13.1 $2.16 6/15/20236,080,000 shares $14.08 million +0.2%9.7%12.5 $2.32 5/31/20236,070,000 shares $14.26 million -1.5%9.7%10.9 $2.35 5/15/20236,160,000 shares $16.32 million -17.1%9.8%10.1 $2.65 4/30/20237,430,000 shares $14.41 million +1.5%11.5%13.1 $1.94 4/15/20237,320,000 shares $15.96 million +5.5%11.3%12.8 $2.18 3/31/20236,940,000 shares $13.53 million -2.9%10.8%10.7 $1.95 3/15/20237,150,000 shares $17.30 million +5.3%11.1%8.3 $2.42 2/28/20236,790,000 shares $24.44 million +1.2%10.5%8.2 $3.60 2/15/20236,710,000 shares $29.73 million -4.3%10.5%8.5 $4.43 1/31/20237,010,000 shares $35.82 million -0.7%11.1%7.9 $5.11 1/15/20237,060,000 shares $35.30 million -6.6%14.6%8.2 $5.00 12/30/20227,560,000 shares $29.03 million +4.9%15.6%9.5 $3.84 12/15/20227,210,000 shares $23.94 million -0.6%14.9%10.6 $3.32 11/30/20227,250,000 shares $26.54 million +16.4%16.0%18.6 $3.66 11/15/20226,230,000 shares $27.47 million -4.3%13.7%18.4 $4.41 10/31/20226,510,000 shares $28.90 million +0.3%14.4%26.4 $4.44 10/15/20226,490,000 shares $30.50 million +1.7%14.3%27.9 $4.70 9/30/20226,380,000 shares $30.75 million -0.6%15.0%24.5 $4.82 9/15/20226,420,000 shares $34.92 million -3.0%15.1%23.1 $5.44 8/31/20226,620,000 shares $45.15 million -2.2%16.9%22.4 $6.82 8/15/20226,770,000 shares $62.83 million -1.7%17.3%23.6 $9.28The “Perfect Storm” for Gold (Ad)Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! ADCT Short Interest - Frequently Asked Questions What is ADC Therapeutics' current short interest? Short interest is the volume of ADC Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 993,100 shares of ADCT short. 1.81% of ADC Therapeutics' shares are currently sold short. Learn More on ADC Therapeutics' current short interest. What is a good short interest ratio for ADC Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ADCT shares currently have a short interest ratio of 1.0. Learn More on ADC Therapeutics's short interest ratio. Which institutional investors are shorting ADC Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ADC Therapeutics: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for ADC Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.81% of ADC Therapeutics' floating shares are currently sold short. Is ADC Therapeutics' short interest increasing or decreasing? ADC Therapeutics saw a increase in short interest in March. As of March 31st, there was short interest totaling 993,100 shares, an increase of 5.7% from the previous total of 939,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ADC Therapeutics' float size? ADC Therapeutics currently has issued a total of 82,810,000 shares. Some of ADC Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ADC Therapeutics currently has a public float of 54,790,000 shares. How does ADC Therapeutics' short interest compare to its competitors? 1.81% of ADC Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to ADC Therapeutics: Esperion Therapeutics, Inc. (11.82%), Amarin Co. plc (4.39%), Atai Life Sciences (4.81%), Nature's Sunshine Products, Inc. (0.60%), Organogenesis Holdings Inc. (9.35%), Rani Therapeutics Holdings, Inc. (16.70%), Nkarta, Inc. (9.81%), Adlai Nortye Ltd. (0.02%), UroGen Pharma Ltd. (17.87%), Precigen, Inc. (13.66%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short ADC Therapeutics stock? Short selling ADCT is an investing strategy that aims to generate trading profit from ADC Therapeutics as its price is falling. ADCT shares are trading down $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ADC Therapeutics? A short squeeze for ADC Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ADCT, which in turn drives the price of the stock up even further. How often is ADC Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ADCT, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: ESPR Short Squeeze AMRN Short Squeeze ATAI Short Squeeze NATR Short Squeeze ORGO Short Squeeze RANI Short Squeeze NKTX Short Squeeze ANL Short Squeeze URGN Short Squeeze PGEN Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:ADCT) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIYour Money is Not SafeAmerican AlternativeHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceSHOCKING Crypto Leak…Crypto 101 MediaMy biggest AI fearParadigm Press